One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical ...
Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...
In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity ...
GH001 cleared by FDA for U.S. clinical investigation, enabling U.S. subject enrollmentCompany to seek FDA alignment on global Phase 3 program replicating Phase 2b designPhase 3 initiation targeted for ...
Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...
In a new observational study published in Cancer, commonly prescribed chronic medications did not affect the efficacy of ...
Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...
Mayo Clinic researchers have developed a smartwatch-based alert system that signals parents at the earliest signs of a ...
AI’s true promise is turning clinical development from a bottleneck into a throughput engine for human health. Drug discovery ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
CR-001 IND cleared by U.S. FDA; Phase 1/2 ASCEND global clinical trial to evaluate CR-001 in first-line and previously ...
A recent study by Case Western Reserve University and University Hospitals finds that financial status, rather than race, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback